Literature DB >> 8358880

Low-dose dobutamine stress test for the evaluation of cardiac function using ultrafast computed tomography.

O Yamaoka1, H Fujioka, T Haque, Y Nakamura, K Mitsunami, M Kinoshita, K Murata, R Morita.   

Abstract

High dose-dobutamine (DOB) has been previously used as a pharmacological stress test to evaluate wall motion abnormalities. As a result, recent stress echocardiography with low-dose DOB has been reported to be valuable for investigating stunned myocardium after thrombolysis. However, echocardiography requires an operator's skill and experience to evaluate wall motion abnormalities which are subjectively determined by the observer. In contrast, ultrafast computed tomography (UFCT) does not necessarily require extreme technical skill and experience. To evaluate the feasibility of stress UFCT with low-dose DOB, we scanned 10 normal subjects along the short-axis by 8-slice-multicine mode. After scanning at rest for baseline, we scanned during the administration of 4 and 8 micrograms/kg/min of DOB, respectively, for 5 min. Ejection fraction, contraction, and thickening were higher during 8 micrograms/kg/min of DOB than during 4 micrograms/kg/min of DOB and baseline, while the above values were higher during 4 micrograms/kg/min of DOB than during baseline (p < 0.01). It was possible to detect changes of cardiac function and wall motion due to low-dose DOB by UFCT. We therefore conclude that UFCT is a reliable modality for evaluating cardiac function and wall motion for low-dose DOB stress test because of its excellent spatial and contrast resolution.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358880     DOI: 10.1002/clc.4960160604

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  2 in total

1.  [Quantitative determination of left ventricular myocardial perfusion with electron beam computerized tomography].

Authors:  R Rienmüller; C Baumgartner; R Kern; S Harb; R Aigner; G Fueger; W Weihs
Journal:  Herz       Date:  1997-04       Impact factor: 1.443

Review 2.  Evaluating coronary artery disease noninvasively--which test for whom?

Authors:  T M Chou; T M Amidon
Journal:  West J Med       Date:  1994-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.